مكتبة

Authors : Szabo E; Department of Biochemistry, Institute of Biochemistry and Molecular Biology, Semmelweis University, 37-47 Tuzolto St., 1094 Budapest, Hungary.; Nemes-Nikodem E

Subjects: Dihydrolipoamide Dehydrogenase*/Dihydrolipoamide Dehydrogenase*/Dihydrolipoamide Dehydrogenase*/genetics; Humans ; Protein Conformation

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 28; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Biochemical characterization of patients with dihydrolipoamide dehydrogenase deficiency

Authors : Parith Wongkittichote; Sanmati R. Cuddapah; Stephen R. Master

Subjects: dihydrolipoamide dehydrogenase deficiency; lipoic acid; lysine degradation

Source: JIMD Reports, Vol 64, Iss 5, Pp 367-374 (2023)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib

Authors : Yu Feng; Hongmei Luo; Jingcao Huang

Subjects: Cytology; QH573-671

Source: Cell Death and Disease, Vol 15, Iss 8, Pp 1-11 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells.

Authors : Tabolacci C; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.; Giordano D

Subjects: Dihydrolipoamide Dehydrogenase* ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/metabolism

Source: Molecules (Basel, Switzerland) [Molecules] 2022 Nov 12; Vol. 27 (22). Date of Electronic Publication: 2022 Nov 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer's disease

Authors : Waqar Ahmad; Paul R. Ebert

Subjects: Alzheimer's disease; Amyloid beta; C. elegans

Source: Genes and Diseases, Vol 8, Iss 6, Pp 849-866 (2021)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Rg3 regulates myocardial pyruvate metabolism via P300-mediated dihydrolipoamide dehydrogenase 2-hydroxyisobutyrylation in TAC-induced cardiac hypertrophy

Authors : Jingyu Ni; Hao Zhang; Xiaodan Wang

Subjects: Cytology; QH573-671

Source: Cell Death and Disease, Vol 13, Iss 12, Pp 1-12 (2022)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The phenotypic spectrum of dihydrolipoamide dehydrogenase deficiency in Saudi Arabia

Authors : Anar Alfarsi; Majid Alfadhel; Seham Alameer

Subjects: Dihydrolipoamide dehydrogenase deficiency; Lactic acidosis; Hypoglycemia

Source: Molecular Genetics and Metabolism Reports, Vol 29, Iss , Pp 100817- (2021)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Dihydrolipoamide dehydrogenase deficiency in five siblings with variable phenotypes, including fulminant fatal liver failure despite good engraftment of transplanted liver

In depth profiling of dihydrolipoamide dehydrogenase deficiency in primary patients fibroblasts reveals metabolic reprogramming secondary to mitochondrial dysfunction

Dihydrolipoamide dehydrogenase, pyruvate oxidation, and acetylation-dependent mechanisms intersecting drug iatrogenesis

Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase.

Biochemical characterization of patients with dihydrolipoamide dehydrogenase deficiency

Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib

Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells.

Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer's disease

Rg3 regulates myocardial pyruvate metabolism via P300-mediated dihydrolipoamide dehydrogenase 2-hydroxyisobutyrylation in TAC-induced cardiac hypertrophy

The phenotypic spectrum of dihydrolipoamide dehydrogenase deficiency in Saudi Arabia

اتصل بنا

اتبع